Verdence Capital Advisors LLC Halozyme Therapeutics, Inc. Transaction History

Verdence Capital Advisors LLC

$1.23 Billion
Q3 2024

A detailed history of Verdence Capital Advisors LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 13,232 shares of HALO stock, worth $604,040. This represents 0.06% of its overall portfolio holdings.

Number of Shares

13,232

Previous 12,980 1.94%

Holding current value

$604,040

Previous $679,000 11.49%

% of portfolio

0.06%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$51.3 - $64.42 $12,927 - $16,233	252 Added 1.94%	13,232 $757,000
Q2 2024 Jul 25, 2024	SELL	$37.81 - $52.4 $2,268 - $3,144	-60 Reduced 0.46%	12,980 $679,000
Q1 2024 Apr 25, 2024	SELL	$33.68 - $41.95 $51,665 - $64,351	-1,534 Reduced 10.53%	13,040 $530,000
Q4 2023 Jan 31, 2024	BUY	$33.32 - $42.1 $4,664 - $5,894	140 Added 0.97%	14,574 $538,000
Q3 2023 Oct 25, 2023	SELL	$36.46 - $44.03 $6,927 - $8,365	-190 Reduced 1.3%	14,434 $551,000
Q2 2023 Jul 28, 2023	BUY	$30.28 - $38.74 $6,237 - $7,980	206 Added 1.43%	14,624 $527,000
Q1 2023 Apr 24, 2023	SELL	$32.86 - $55.7 $11,303 - $19,160	-344 Reduced 2.33%	14,418 $550,000
Q4 2022 Jan 20, 2023	SELL	$40.06 - $59.44 $36,614 - $54,328	-914 Reduced 5.83%	14,762 $0
Q3 2022 Nov 15, 2022	BUY	$38.53 - $51.78 $5,702 - $7,663	148 Added 0.95%	15,676 $620,000
Q2 2022 Aug 08, 2022	BUY	$37.35 - $48.3 $56,286 - $72,788	1,507 Added 10.75%	15,528 $683,000
Q1 2022 May 02, 2022	BUY	$31.97 - $41.06 $8,024 - $10,306	251 Added 1.82%	14,021 $559,000
Q4 2021 Jan 26, 2022	BUY	$31.82 - $40.75 $72,613 - $92,991	2,282 Added 19.86%	13,770 $554,000
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $269 - $324	-7 Reduced 0.06%	11,488 $467,000
Q2 2021 Aug 06, 2021	SELL	$38.84 - $51.31 $1,398 - $1,847	-36 Reduced 0.31%	11,495 $522,000
Q1 2021 May 11, 2021	SELL	$39.51 - $51.45 $790 - $1,029	-20 Reduced 0.17%	11,531 $481,000
Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $4,207 - $7,110	163 Added 1.43%	11,551 $493,000
Q4 2017 Jan 30, 2020	BUY	$16.75 - $20.8 $190,749 - $236,870	11,388	11,388 $231,000

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.36B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Account

Verdence Capital Advisors LLC Halozyme Therapeutics, Inc. Transaction History